600
Participants
Start Date
November 4, 2013
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
The risk assessment questionnaire
Blood specimens
tumor tissue samples will be requested
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester, East White Plains
Memorial Sloan Kettering Nassau, Uniondale
Cold Springs Harbor Laboratory (Specimen Analysis), Cold Spring Harbor
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
Weill Cornell Medical College (Specimen Analysis), New York
Shaare Zedek Medical Center, Jerusalem
Weizmann Institute of Science (Specimen Analysis), Rehovot
Sheba Medical Center, Tel Litwinsky
Abramson Cancer Center at University of Pennsylvania Medical Center, Philadelphia
Abramson Cancer Center at Penn Medicine
OTHER
Shaare Zedek Medical Center
OTHER
Sheba Medical Center
OTHER_GOV
Dana-Farber Cancer Institute
OTHER
Johns Hopkins University
OTHER
Memorial Sloan Kettering Cancer Center
OTHER